DAFNA Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,750
| Closed | -$4.5M | – | 88 |
|
|
2021
Q2 | $4.5M | Buy |
8,750
+1,488
| +20% | +$764K | 0.94% | 28 |
|
|
2021
Q1 | $5.68M | Hold |
7,262
| – | – | 1.35% | 21 |
|
|
2020
Q4 | $3.96M | Buy |
7,262
+390
| +6% | +$212K | 1.18% | 21 |
|
|
2020
Q3 | $3.15M | Sell |
6,872
-3,434
| -33% | -$1.57M | 1.02% | 25 |
|
|
2020
Q2 | $6.35M | Hold |
10,306
| – | – | 1.83% | 17 |
|
|
2020
Q1 | $4.9M | Buy |
10,306
+1,180
| +13% | +$561K | 2.05% | 13 |
|
|
2019
Q4 | $5.29M | Sell |
9,126
-1,400
| -13% | -$812K | 1.82% | 14 |
|
|
2019
Q3 | $6.93M | Buy |
10,526
+4,831
| +85% | +$3.18M | 2.61% | 8 |
|
|
2019
Q2 | $4.41M | Buy |
5,695
+1,706
| +43% | +$1.32M | 1.66% | 18 |
|
|
2019
Q1 | $2.82M | Hold |
3,989
| – | – | 1.22% | 28 |
|
|
2018
Q4 | $1.87M | Buy |
3,989
+855
| +27% | +$400K | 0.93% | 32 |
|
|
2018
Q3 | $2.7M | Buy |
3,134
+1,389
| +80% | +$1.2M | 1.11% | 32 |
|
|
2018
Q2 | $1.2M | Sell |
1,745
-861
| -33% | -$594K | 0.56% | 46 |
|
|
2018
Q1 | $1.16M | Hold |
2,606
| – | – | 0.56% | 50 |
|
|
2017
Q4 | $1.15M | Hold |
2,606
| – | – | 0.62% | 47 |
|
|
2017
Q3 | $1.28M | Buy |
+2,606
| New | +$1.28M | 0.8% | 39 |
|
|
2017
Q2 | – | Sell |
-2,648
| Closed | -$1.75M | – | 80 |
|
|
2017
Q1 | $1.75M | Sell |
2,648
-3,172
| -55% | -$2.1M | 1.48% | 24 |
|
|
2016
Q4 | $1.95M | Sell |
5,820
-1,598
| -22% | -$534K | 1.71% | 23 |
|
|
2016
Q3 | $2.23M | Hold |
7,418
| – | – | 1.55% | 23 |
|
|
2016
Q2 | $1.28M | Hold |
7,418
| – | – | 1.02% | 33 |
|
|
2016
Q1 | $1.66M | Buy |
7,418
+2,714
| +58% | +$608K | 1.43% | 21 |
|
|
2015
Q4 | $2.86M | Buy |
4,704
+2,105
| +81% | +$1.28M | 2.55% | 11 |
|
|
2015
Q3 | $1.34M | Sell |
2,599
-928
| -26% | -$477K | 1.33% | 23 |
|
|
2015
Q2 | $1.54M | Buy |
+3,527
| New | +$1.54M | 1.31% | 28 |
|